关注
Mariana Scaranti
Mariana Scaranti
The Royal Marsden Hospital
在 icr.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploiting the folate receptor α in oncology
M Scaranti, E Cojocaru, S Banerjee, U Banerji
Nature reviews clinical oncology 17 (6), 349-359, 2020
3722020
Endocrine side effects of cancer immunotherapy
P Cukier, FC Santini, M Scaranti, AO Hoff
Endocrine-related cancer 24 (12), T331-T347, 2017
1812017
Emerging therapeutic targets in bladder cancer
BA Carneiro, JJ Meeks, TM Kuzel, M Scaranti, SA Abdulkadir, FJ Giles
Cancer Treatment Reviews 41 (2), 170-178, 2015
1762015
Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial
SCS da Costa, RC Bonadio, FCG Gabrielli, AS Aranha, MLN Dias Genta, ...
Journal of Clinical Oncology 37 (33), 3124-3131, 2019
822019
Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: A single-centre, open-label, phase 1 …
C Guo, M Chénard-Poirier, D Roda, M de Miguel, SJ Harris, IM Candilejo, ...
The Lancet Oncology 21 (11), 1478-1488, 2020
522020
Vitamin D and cancer: does it really matter?
M Scaranti, G de Castro Júnior, AO Hoff
Current Opinion in Oncology 28 (3), 205-209, 2016
282016
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy
F Chamberlain, E Cojocaru, M Scaranti, J Noujaim, A Constantinou, ...
Medical Oncology 37, 1-8, 2020
262020
Targeting PARP1 to enhance anticancer checkpoint immunotherapy response: rationale and clinical implications
CWS Wanderley, TS Correa, M Scaranti, FQ Cunha, R Barroso-Sousa
Frontiers in Immunology 13, 816642, 2022
242022
Radiological patterns of drug-induced interstitial lung disease (DILD) in early-phase oncology clinical trials
A Terbuch, C Tiu, IM Candilejo, M Scaranti, A Curcean, D Bar, ...
Clinical Cancer Research 26 (18), 4805-4813, 2020
202020
CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report
AC Vieira, CB Xavier, TD Vieira, FM Carvalho, M Scaranti, RR Munhoz, ...
Gynecologic Oncology Reports 36, 2021
132021
Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma.
JS Lopez, RS Kristeleit, R Rulach, NM Haris, M Scaranti, PJ Mulholland, ...
Journal of Clinical Oncology 37 (15_suppl), 2025-2025, 2019
102019
Response to paclitaxel in an adult patient with advanced Kaposiform hemangioendothelioma
JM Mota, M Scaranti, LG Fonseca, DA Tolói, VP de Camargo, RR Munhoz, ...
Case Reports in Oncology 9 (2), 481-487, 2016
72016
Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial.
S Silva, RRC Colombo Bonadio, F Gabrielli, AS Aranha, ML Genta, ...
Journal of Clinical Oncology 36 (15_suppl), 5523-5523, 2018
52018
Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp
M Scaranti, DN Rodrigues, U Banerji
European Journal of Cancer 122, 9-11, 2019
42019
Breast and gynecologic cancers as a Brazilian health priority
A Nogueira-Rodrigues, DD Rosa, DA Suzuki, E Paulino, LCG Landeiro, ...
Revista da Associação Médica Brasileira 69 (suppl 1), e2023S120, 2023
32023
Abstract CT140: Proof-of-concept evidence of immune modulation by blockade of the phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway in the phase I dose escalation …
JS Lopez, A Biondo, C Tiu, M Scaranti, M Ameratunga, A Zachariou, ...
Cancer Research 80 (16_Supplement), CT140-CT140, 2020
32020
Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil
DAP de Andrade, APG Guimarães, AC de Melo, A Nogueira-Rodrigues, ...
Frontiers in Oncology 13, 1133277, 2023
12023
The addition of PD-1/PD-L1 axis blockade to BRAF and MEK inhibition for advanced melanoma patients harboring BRAF mutations: a systematic review and meta-analysis
MFSA Ribeiro, CB Xavier, AAL Pereira, M Scaranti, LDBB Faria, ...
Brazilian Journal of Oncology 18, 1-15, 2022
12022
Clinical impact of molecular profiling of cervical cancer (CC) patients (pts) in a dedicated phase I (P1) unit
M Scaranti, R Caldwell, MS Miralles, R Shinde, A Pal, JE Ang, A Biondo, ...
Annals of Oncology 30, v430, 2019
12019
Distinct radiological patterns of drug-induced pneumonitis (R-DIP) in early-phase clinical trials and predictive factors affecting outcome: A 10-year systematic review from the …
A Terbuch, I Moreno Candilejo, M Scaranti, D Bar, M Estevez Timon, ...
Journal of Clinical Oncology 37 (15_suppl), 3088-3088, 2019
12019
系统目前无法执行此操作,请稍后再试。
文章 1–20